← Leaderboards
Caitlyn N Meinzer
Columbia University Health Sciences
$3,665,869
Attributed
$21,995,212
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7M · FY2017–22$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$21,995,212 · 1
By mechanism
U01$21,995,212 · 1
Top collaborators
- Joseph Paul Broderick5 shared
- Hooman Kamel5 shared
- Wt Longstreth5 shared
- David L Tirschwell5 shared
- Mitchell S Elkind4 shared
- Randolph S Marshall1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Randolph S Marshall$10,866,382
- Marco R Di Tullio$6,840,545
- Philip Stieg$589,926
- Edward Sander Connolly$9,326,629
- Dana Leifer$482,711
Others in their field
Other Emerging Leaders on “Echocardiography”
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,485,488
- Ionut Bebu · George Washington University$10,066,665
- Barbara Halina Braffett · George Washington University$10,066,665
- Bruce Psaty · University Of Washington$7,081,269
- Christoph Hornik · Duke University$5,628,142
- Wendy White · Tougaloo College$5,121,211
Research focus
EchocardiographyActive ControlAnticoagulant TherapyAlternative TreatmentAnticoagulantsArteriesAspirinAtherosclerosisAtrial FibrillationAortic ArchArterial Fatty StreakBiological MarkersBiomarker-DrivenBloodBlood CoagulationBrainBrain Natriuretic PeptideCardiacClinical TrialsCox ModelsBaseDesignDouble-Blind MethodEkg P Wave
Grant awards (5)
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$2,310,548
U01 · FY2022 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$1,790,846
U01 · FY2021 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$6,861,083
U01 · FY2020 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$6,959,908
U01 · FY2018 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$4,072,827
U01 · FY2017 · NS